ID
14824
Description
Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC); ODM derived from: https://clinicaltrials.gov/show/NCT00517920
Link
https://clinicaltrials.gov/show/NCT00517920
Keywords
Versions (1)
- 4/29/16 4/29/16 -
Uploaded on
April 29, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Advanced Hepatocellular Carcinoma NCT00517920
Eligibility Advanced Hepatocellular Carcinoma NCT00517920
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
vegf/pdgf/tki therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0078058
- UMLS CUI [2]
- C0032200
Description
Child-Pugh score class C
Data type
boolean
Alias
- UMLS CUI [1]
- C4039103
Description
proteinuria
Data type
boolean
Alias
- UMLS CUI [1]
- C0033687
Description
hypertension
Data type
boolean
Alias
- UMLS CUI [1]
- C0020538
- UMLS CUI [2]
- C2704328
Description
left ventricular ejection fraction
Data type
boolean
Alias
- UMLS CUI [1]
- C0428772
Description
anticoagulation therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0003281
Similar models
Eligibility Advanced Hepatocellular Carcinoma NCT00517920
- StudyEvent: Eligibility
C2239176 (UMLS CUI [2])
C0032200 (UMLS CUI [2])
C2704328 (UMLS CUI [2])